Investors continue to back fund operations with a new raise in the past week. Data providers are opening distribution channels, senior commercial hires signal a go-to-market push, and AI remains a roadmap priority.
NEW & UPDATED PRODUCTS
Specter has introduced Specter Agent, an AI agent that sources companies, researches markets and runs repeatable workflows across its private-market intelligence and the web. ↗
CAIS has released a set of platform enhancements spanning its CAISey assistant, new capital markets capabilities and expanded integrations. ↗
ROYC has launched an AI agent that lets GPs and fund administrators query committed capital, calls, distributions and compliance records in natural language. ↗
Taghash has released a WhatsApp deal-flow agent that reads inbound pitch decks in context, matches them to existing deals and files attachments and activity to the right record automatically. ↗
Drooms has brought full Q&A and user and permission management to its mobile app, letting deal teams run the Q&A process and manage access from a phone. ↗
qashqade has enabled natural-language AI querying of its private markets platform through the Model Context Protocol, with no additional plugins or tooling required. ↗
FINTRX has launched Fin, an always-on AI agent that surfaces advisor moves, allocation shifts, filings and M&A activity inside email, Slack, Teams and calendar tools. ↗
DEAL ACTIVITY
Fundcraft has raised €12m in growth financing co-led by Riverside Acceleration Capital and CCAP Investments, taking total capital raised to €40m. ↗
PARTNERSHIPS & INTEGRATIONS
Intapp has released a DealCloud with Celeste plug-in for ChatGPT for Financial Services, letting deal teams query their firm’s client, deal, investor and relationship records from within ChatGPT. ↗
Datasite is integrating with Rogo so dealmakers can run Rogo AI tools on live, permissioned Datasite deal content without exporting documents. ↗
iConnections has brought Carta into its Get Verified programme, so Carta fund-manager clients can share independent, administrator-sourced performance data directly with allocators researching them. ↗
Tracxn has made its private-market intelligence accessible directly inside ChatGPT using the Model Context Protocol, enabling plain-language queries within AI workflows. ↗
Quantios has expanded its partnership with Laserfiche specialist Manx Business Solutions to add intelligent document management around its Quantios Core platform for trust and corporate services firms. ↗
CB Insights now distributes select private-markets datasets through Nasdaq Data Link, aimed at closing the disclosure gap for institutional investors. ↗
NEW CLIENTS
Quantium alongside A11, has been selected by European VC Project A Ventures (c.€1.2bn platform) to rebuild its data foundation, delivering faster reporting and AI-ready data. ↗
Chronograph has been adopted by lower-middle-market PE firm Renovus Capital Partners (c.$2.5bn AUM) to automate portfolio data collection, valuations and reporting. ↗
OFFICE & PERSONNEL
Arcesium has named Brian Rosenberg President, Revenue and Commercial, appointing him to its Executive Committee to lead go-to-market and client development; he was previously President and CRO at Wilshire Indexes. ↗
PitchBook has appointed Brian LaMonica as General Manager and Managing Director of its New York office to drive commercial growth. ↗
Titanbay has hired Ludovico Buffo to build partnerships with Italian banks, wealth managers and asset managers. ↗
VENDOR RESEARCH & WHITEPAPERS
Axial has published its 2H 2026 M&A Outlook survey, in which 91% of dealmakers expect competition to hold or increase, only 45% of buyers will stretch on valuation, and 57% cite valuation gaps as the top reason deals failed. ↗
Altus Group has released its Q2 2026 US commercial real estate report, showing dollar volume rising faster than deal count, with a breakdown of which sectors captured the most capital. ↗
Forge has released Future Private, produced with Charles Schwab, a data-driven report on the trends shaping private markets and their growing role in the broader capital markets. ↗
Fintent has published a healthcare M&A propensity analysis flagging biotech and pharma (2.02x) and therapy and rehabilitation (1.52x) as the sub-sectors most primed for dealmaking against a 0.98x sector baseline. ↗
